GN
Genelux Corporation (GNLX)
NASDAQ·Healthcare·Biotechnology
$2.84
-6.44%
Mkt Cap $106.46M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$17.33
Range $16.00 – $20.00
Implied Upside
+511.3%
Consensus $17.33 vs current $2.84
NASDAQ·Healthcare·Biotechnology
$2.84
-6.44%
Mkt Cap $106.46M
No recent rating data.
Price Target (3 analysts)
$17.33
Range $16.00 – $20.00
+511.3%
Consensus $17.33 vs current $2.84